Search
for
Sort by
Research 31–60 of 566
- Metabolic Effect at Six and Twelve Months of Cyproterone Acetate (2 mg) Combined with Ethinyl Estradiol (35 μg) in 31 Patients
- PHARMACOVIGILANCE STUDY OF SIDE EFFECTS ASSOCIATED WITH LEVONORGESTROL -ETHINYL ESTRADIOL AND DEPOTMEDROXY PROGESTERONE ACETATE
- To evaluate the outcome of combined therapy of cyproterone acetate and ethinyl estradiol in PCOS
- The Effects of Metformin, Ethinyl Estradiol/Cyproterone Acetate, and Metformin Ethinyl Estradiol/Cyproterone Acetate Combination Therapy on Carotid Artery Intima-media Thickness in Patients with Polycystic Ovary Syndrome
- Effects of 17 α-ethinylestradiol,Norethindrone and Levonorgestrel on Root Growth of Arabidopsis thaliana
- Comparative analysis between ethinyl estradiol & cyperoterone acetate with or without metformin therapy in the treatment of polycyctic ovarian syndrome induced hirsutism
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Hormonal contraceptives: pharmacology tailored to women's health
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women
- Dienogest
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Hair problems in women
- Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment
- Assessment, diagnosis and treatment of a patient with hirsutism
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- Treatment of hyperandrogenism in women
- Androstanediolglucuronide: A parameter for peripheral androgen activity before and during therapy with cyproterone acetate
- Thrombotic risk minimization for Diane‐35 and generics
- Die Behandlung androgenisierter Frauen mit intramuskulär applizierbarem Cyproteronacetat
- ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne
- Anti-Androgen Treatment of Hirsute Women: A Study on Stress Responses
- Polycystic ovary syndrome
- Steroid inhibitors of androgen-potentiated actions on skin
- PCOS and Obesity: Contraception Challenges
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- Diagnosis and treatments of hirsutism: where are we?
- [Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms (author's transl)].